Terms And Conditions
  1. Home
  2. Terms And Conditions
INOVIQ Limited (ASX: IIQ): INOVIQ made signif...
By ACE Investors / 28 May 2025
Read More
EZZ Life Science Holdings Limited (ASX: EZZ):...
By ACE Investors / 26 May 2025
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 26 May 2025
Read More
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN...
By ACE Investors / 26 May 2025
Read More
Immutep Limited (ASX: IMM) – Deep Pipeline ...
By ACE Investors / 20 May 2025
Read More
Avita Medical Inc. (ASX: AVH) – From a $455...
By ACE Investors / 20 May 2025
Read More
PureTech Health Plc. (NASDAQ: PRTC): Uniquely...
By ACE Investors / 16 May 2025
Read More
Disc Medicine, Inc. (NASDAQ: IRON): Transform...
By ACE Investors / 15 May 2025
Read More
Neuren Pharmaceuticals Limited (ASX: NEU): Lo...
By ACE Investors / 15 May 2025
Read More
Biogen Inc. (NASDAQ: BIIB): Executing on key ...
By ACE Investors / 12 May 2025
Read More
Syntara Limited (ASX: SNT): Announced Positiv...
By ACE Investors / 12 May 2025
Read More
Quidel Corporation (NASDAQ: QDEL): Rationaliz...
By ACE Investors / 07 May 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors